Therapy Areas: Devices
AngioDynamics reports 24-month PRESERVE data showing durable NanoKnife outcomes in prostate cancer
13 May 2026 - Medical technology company AngioDynamics Inc (NASDAQ: ANGO) reported on Wednesday that the two-year results from the PRESERVE pivotal trial of its NanoKnife System demonstrated sustained...
Cepheid receives CE mark for IVDR‑compliant gastrointestinal PCR panel
Vector Science & Therapeutics secures three-year manufacturing partnership with MPP Group to expand peptide pipeline
11 May 2026 - Medical technology company Vector Science & Therapeutics (TSXV: PAIN) announced on Monday that it has entered a three-year development and manufacturing agreement with MPP Group LLC ...
Abingdon Health supports UK launch of LVOne stroke triage test
11 May 2026 - Abingdon Health plc (AIM: ABDX) (OTCQB: ABDXF) reported on Monday that its customer UpFront Diagnostics has commercially launched the LVOne stroke triage blood test in the UK following U...
Fesarius Therapeutics reports publication of DermiSphere hDRT data
1 May 2026 - Bioregenerative technology company FesariusTherapeutics Inc announced on Thursday the publication of its peer reviewed evidence of category leading speed of 'neodermis' formatio...
Shield Therapeutics announces Phase II trial initiation of ACCRUFeR in Japan for PAH
27 April 2026 - Pharmaceutical company Shield Therapeutics plc (LSE: STX) announced on Monday that its partner MEDLEAP Pharma, a subsidiary of Vital KSK Holdings Inc, has enrolled the first patient in...